CVS Health Corporation (NYSE:CVS) will be announcing its earnings results before the market opens on Monday, November 6th. Analysts expect the company to announce earnings of $1.49 per share for the quarter. CVS Health Corporation has set its Q3 guidance at $1.47-1.50 EPS and its FY17 guidance at $5.83-5.93 EPS.

CVS Health Corporation (NYSE:CVS) last announced its quarterly earnings results on Tuesday, August 8th. The pharmacy operator reported $1.33 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.31 by $0.02. The firm had revenue of $45.69 billion during the quarter, compared to analyst estimates of $45.36 billion. CVS Health Corporation had a return on equity of 17.47% and a net margin of 2.93%. CVS Health Corporation’s quarterly revenue was up 4.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.32 earnings per share. On average, analysts expect CVS Health Corporation to post $5.88 EPS for the current fiscal year and $6.34 EPS for the next fiscal year.

Shares of CVS Health Corporation (CVS) opened at 68.99 on Monday. The stock has a market cap of $70.13 billion, a price-to-earnings ratio of 13.74 and a beta of 0.92. CVS Health Corporation has a one year low of $68.16 and a one year high of $85.49. The company has a 50 day moving average price of $78.14 and a 200-day moving average price of $78.59.

The business also recently announced a quarterly dividend, which will be paid on Friday, November 3rd. Investors of record on Tuesday, October 24th will be issued a $0.50 dividend. The ex-dividend date is Monday, October 23rd. This represents a $2.00 annualized dividend and a yield of 2.90%. CVS Health Corporation’s dividend payout ratio (DPR) is presently 39.92%.

Several research firms have commented on CVS. Royal Bank Of Canada began coverage on shares of CVS Health Corporation in a research note on Tuesday, September 19th. They issued an “outperform” rating and a $95.00 price target for the company. Robert W. Baird restated a “hold” rating and issued a $77.00 price target on shares of CVS Health Corporation in a research note on Friday. Loop Capital began coverage on shares of CVS Health Corporation in a research note on Thursday, August 24th. They issued a “hold” rating and a $83.00 price target for the company. Jefferies Group LLC set a $86.00 price target on shares of CVS Health Corporation and gave the stock a “hold” rating in a research note on Wednesday, October 18th. Finally, Wolfe Research downgraded shares of CVS Health Corporation from an “outperform” rating to a “market perform” rating and dropped their price target for the stock from $89.00 to $82.00 in a research note on Monday, August 14th. One analyst has rated the stock with a sell rating, nine have given a hold rating and fifteen have issued a buy rating to the stock. CVS Health Corporation currently has a consensus rating of “Buy” and an average price target of $87.98.

In other news, Director Richard J. Swift sold 2,500 shares of the business’s stock in a transaction dated Wednesday, August 16th. The shares were sold at an average price of $79.62, for a total transaction of $199,050.00. Following the transaction, the director now directly owns 3,258 shares in the company, valued at $259,401.96. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Thomas M. Moriarty sold 90,267 shares of the business’s stock in a transaction dated Monday, September 11th. The stock was sold at an average price of $79.61, for a total transaction of $7,186,155.87. Following the transaction, the executive vice president now owns 70,102 shares in the company, valued at $5,580,820.22. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 716,625 shares of company stock worth $58,318,431. Company insiders own 0.61% of the company’s stock.

Institutional investors have recently modified their holdings of the company. Fieldpoint Private Securities LLC increased its stake in shares of CVS Health Corporation by 333.3% during the second quarter. Fieldpoint Private Securities LLC now owns 1,300 shares of the pharmacy operator’s stock worth $105,000 after acquiring an additional 1,000 shares during the period. Optimum Investment Advisors increased its stake in shares of CVS Health Corporation by 20.0% during the second quarter. Optimum Investment Advisors now owns 3,444 shares of the pharmacy operator’s stock worth $277,000 after acquiring an additional 573 shares during the period. Bluefin Trading LLC acquired a new position in shares of CVS Health Corporation during the second quarter worth about $298,000. Keel Point LLC increased its stake in shares of CVS Health Corporation by 16.0% during the second quarter. Keel Point LLC now owns 3,824 shares of the pharmacy operator’s stock worth $308,000 after acquiring an additional 528 shares during the period. Finally, Wafra Investment Advisory Group Inc. NY acquired a new position in shares of CVS Health Corporation during the second quarter worth about $507,000. Institutional investors and hedge funds own 81.64% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This news story was originally posted by American Banking News and is owned by of American Banking News. If you are accessing this news story on another website, it was stolen and republished in violation of US and international copyright and trademark legislation. The legal version of this news story can be accessed at https://www.americanbankingnews.com/2017/10/30/cvs-health-corporation-cvs-to-release-quarterly-earnings-on-monday.html.

About CVS Health Corporation

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Earnings History for CVS Health Corporation (NYSE:CVS)

Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.